Market intelligence
KLRASector not reported
Kailera Therapeutics, Inc. insider activity
In the last 90 days, 14 corporate insiders purchased $972,250,048 of stock on the open market.
SEC-reported filing activity is provided for research purposes and is not investment advice.
- 90-day C-suite buyers
- 0
- 90-day purchase value
- $972,250,048
- Corporate buyers
- 14
- Latest transaction
- Apr 20, 2026
Executive filings
Open-market transaction history
Purchase and sale summaries are ordered by the latest reported transaction date.
